Parkinson's disease; modern treatment

Low-frequency genetic variants in GAK enhance Golgi function and protect against Parkinson's disease.

medRxiv : the preprint server for health sciences·2025

Parkinson's disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration.

NPJ Parkinson's disease·2021

Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML.

Oncoimmunology·2021

Vesical Imaging-Reporting and Data System (VI-RADS®): Initial experience in the classification of muscle-invasive bladder cancer.

Actas urologicas espanolas·2021

Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder.

European journal of neurology·2019

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

NPJ Parkinson's disease·2019

Vaping, lung injury, and mental health Minnesota 2018-2019.

Minnesota medicine·2021

Characteristics of clinical extrapulmonary nontuberculous mycobacteria isolates in Minnesota, 2013-2017.

Minnesota medicine·2020

When the world comes to us.

Minnesota medicine·2018

Laying down my stethoscope.

Minnesota medicine·2018

Sulfide Mining and Human Health in Minnesota.

Minnesota medicine·2018

The Psychiatric Assistance Line: Six-Month Follow-up on Consultations to Primary Care.

Minnesota medicine·2018

Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.

Clinical parkinsonism & related disorders·2026

Microfluidic nano-in-microcapsules for ph-responsive colonic delivery of 5-ASA: A moving-boundary kinetic approach.

Colloids and surfaces. B, Biointerfaces·2026

Payer coverage principles for precision medicine biomarker testing in oncology.

Journal of managed care & specialty pharmacy·2026

Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention.

ACS central science·2026

Chromatographic Characterization of Nasal and Inhalation Drug Products: A Review of Liquid Chromatography Strategies for Formulation Assessment, Particle Size Correlation, and In Vitro Performance Testing.

Biomedical chromatography : BMC·2026

The Changing Landscape of Global Biopharmaceutical Leadership, 2004-2024.

Therapeutic innovation & regulatory science·2026

Related Experiment Videos

Parkinson's disease; modern treatment

Related Concept Videos

Low-frequency genetic variants in GAK enhance Golgi function and protect against Parkinson's disease.

Parkinson's disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration.

Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML.

Vesical Imaging-Reporting and Data System (VI-RADS®): Initial experience in the classification of muscle-invasive bladder cancer.

Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder.

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

Vaping, lung injury, and mental health Minnesota 2018-2019.

Characteristics of clinical extrapulmonary nontuberculous mycobacteria isolates in Minnesota, 2013-2017.

When the world comes to us.

Laying down my stethoscope.

Sulfide Mining and Human Health in Minnesota.

The Psychiatric Assistance Line: Six-Month Follow-up on Consultations to Primary Care.

Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.

Microfluidic nano-in-microcapsules for ph-responsive colonic delivery of 5-ASA: A moving-boundary kinetic approach.

Payer coverage principles for precision medicine biomarker testing in oncology.

Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention.

Chromatographic Characterization of Nasal and Inhalation Drug Products: A Review of Liquid Chromatography Strategies for Formulation Assessment, Particle Size Correlation, and In Vitro Performance Testing.

The Changing Landscape of Global Biopharmaceutical Leadership, 2004-2024.

Related Experiment Videos

Parkinson's disease; modern treatment

Related Concept Videos

Related Articles